132 related articles for article (PubMed ID: 9489413)
1. [Reasons for chronic expectoration in patients with pulmonary tuberculosis registered in the Central Tuberculosis Registry].
Korzeniewska-Koseła M; Michałowska-Mitczuk D; Wedzicha S; Pawlicka L; Miller M; Kuś J
Pneumonol Alergol Pol; 1997; 65(3-4):181-6. PubMed ID: 9489413
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of patients with chronic pulmonary tuberculosis with expectoration--evaluation of effectiveness].
Michałowska-Mitczuk D; Kuś J
Pneumonol Alergol Pol; 1997; 65(3-4):164-71. PubMed ID: 9489411
[TBL] [Abstract][Full Text] [Related]
3. [Reasons for chronic sputum culture positive tuberculosis--evaluation based on personal experience].
Michałowska-Mitczuk D; Kuś J
Pneumonol Alergol Pol; 1997; 65(3-4):157-63. PubMed ID: 9489410
[TBL] [Abstract][Full Text] [Related]
4. [Reasons for chronic expectoration--case reports].
Michałowska-Mitczuk D; Kuś J
Pneumonol Alergol Pol; 1997; 65(3-4):244-8. PubMed ID: 9489422
[TBL] [Abstract][Full Text] [Related]
5. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
7. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
Banu Rekha VV; Balasubramanian R; Swaminathan S; Ramachandran R; Rahman F; Sundaram V; Thyagarajan K; Selvakumar N; Adhilakshmi AR; Iliayas S; Narayanan PR
Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
[TBL] [Abstract][Full Text] [Related]
8. Factors that effect sputum culture conversion rate in hospitalized patients with pulmonary tuberculosis who were applied directly observation therapy and non-directly observation therapy.
Uzundağ Işeri A; Dulkar G; Selçuk Sönmez O; Yilmaz Aydin L; Yilmaz B
Tuberk Toraks; 2010; 58(1):44-52. PubMed ID: 20517728
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of patients for chronic pulmonary tuberculosis with expectoration--selection and tolerance to drugs].
Michałowska-Mitczuk D; Kuś J
Pneumonol Alergol Pol; 1997; 65(3-4):172-80. PubMed ID: 9489412
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis.
Güler M; Unsal E; Dursun B; Aydln O; Capan N
Int J Clin Pract; 2007 Feb; 61(2):231-5. PubMed ID: 17166185
[TBL] [Abstract][Full Text] [Related]
12. Yield of continued monthly sputum evaluation among tuberculosis patients after culture conversion.
Sundaram V; Fujiwara PI; Driver CR; Osahan SS; Munsiff SS
Int J Tuberc Lung Dis; 2002 Mar; 6(3):238-45. PubMed ID: 11934142
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiological study on factors affecting the hospitalization period of patients with active tuberculosis].
Fujino T; Fusegawa H; Nishiumi M; Okubo Y; Kakizaki T; Maejima K; Sugimori H
Kekkaku; 2008 Aug; 83(8):567-72. PubMed ID: 18800648
[TBL] [Abstract][Full Text] [Related]
14. Frequency of isolated positive sputum cultures among pulmonary tuberculosis patients.
Al-Hakeem MM; Chaudhary AR; Aziz S; Al-Aska AK
Saudi Med J; 2005 Apr; 26(4):634-40. PubMed ID: 15900375
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of pulmonary tuberculosis in a low-prevalence urban area. Compliance and sputum conversion].
Stoffel C; Lorenz R; Arce M; Rico M; Fernández L; Imaz MS
Medicina (B Aires); 2014; 74(1):9-18. PubMed ID: 24561834
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of different subgroups of smear-positive retreatment patients under RNTCP in rural West Bengal, India.
Mukherjee A; Sarkar A; Saha I; Biswas B; Bhattacharyya PS
Rural Remote Health; 2009; 9(1):926. PubMed ID: 19260766
[TBL] [Abstract][Full Text] [Related]
17. Pilot study on multidrug resistant tuberculosis in Nigeria.
Lawson L; Habib AG; Okobi MI; Idiong D; Olajide I; Emenyonu N; Onuoha N; Cuevas LE; Ogiri SO
Ann Afr Med; 2010; 9(3):184-7. PubMed ID: 20710112
[TBL] [Abstract][Full Text] [Related]
18. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
Ye JJ; Wu TS; Chiang PC; Lee MH
J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
[TBL] [Abstract][Full Text] [Related]
19. A subset of clinical status of pulmonary tuberculosis in Southern Taiwan.
Tsai MS; Chong IW; Hwang JJ; Wang TH; Huang MS
Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):136-9. PubMed ID: 15272756
[TBL] [Abstract][Full Text] [Related]
20. A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council.
Tuber Lung Dis; 1992 Feb; 73(1):59-67. PubMed ID: 1326349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
